Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

USP17L7 Activators

USP17L7, or Ubiquitin Specific Peptidase 17 Like Family Member 7, is part of the USP17 subfamily within the larger group of cysteine protease deubiquitinating enzymes (DUBs). This family of enzymes is recognized for its role in removing ubiquitin from ubiquitinated proteins, thereby altering the fate and function of these substrates. The ubiquitination process is a critical post-translational modification that typically targets proteins for degradation via the proteasome, and DUBs like USP17L7 reverse this process, impacting protein stability and function.Located on chromosome 4q13, the gene encoding USP17L7 is part of a cluster of homologous genes that have been proposed to arise due to gene duplication events. These genes code for enzymes that share a conserved USP catalytic domain, although they may exhibit differences in their expression patterns, substrate specificities, and biological roles.

USP17L7's specific function and the pathways it influences are not as thoroughly characterized as those of some other DUBs. However, the modulation of ubiquitination by USP17L7 is likely to be involved in various cellular mechanisms, including signal transduction, regulation of the cell cycle, and apoptosis. DUBs, including USP17L7, play essential roles in maintaining cellular homeostasis and can be involved in the pathogenesis of numerous diseases, such as cancer and neurodegenerative disorders.The expression of USP17L7 can be induced by certain stimuli, such as cytokines, which points to a possible involvement in immune and inflammatory responses. Through its deubiquitinating activity, USP17L7 contributes to the dynamic regulation of protein function within the cell, influencing crucial cellular decisions, such as those related to cell growth, survival, and adaptation to environmental stress.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that may indirectly affect USP17L7 by altering the dynamics of proteasome-mediated protein degradation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor, it could impact USP17L7 by modulating the turnover of ubiquitinated proteins.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Affects ubiquitin ligase activity, potentially influencing USP17L7's role in protein ubiquitination and degradation.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$49.00
$367.00
$2030.00
18
(1)

Similar to thalidomide, it modulates ubiquitin ligase activity, potentially impacting USP17L7.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$98.00
$140.00
$306.00
$459.00
$1224.00
$1958.00
1
(1)

Influences ubiquitin ligase activity, and could indirectly affect USP17L7 functions.

IU1

314245-33-5sc-361215
sc-361215A
sc-361215B
10 mg
50 mg
100 mg
$138.00
$607.00
$866.00
2
(0)

A USP14 inhibitor, which could indirectly affect USP17L7 by altering overall ubiquitin-dependent proteasomal degradation.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of ubiquitin-activating enzyme E1, potentially affecting USP17L7 by modulating ubiquitin conjugation.

P22077

1247819-59-5sc-478536
10 mg
$162.00
(0)

A USP7 inhibitor, potentially affecting USP17L7 through interconnected pathways within the ubiquitin-proteasome system.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$198.00
$650.00
16
(1)

Targets USP2, potentially affecting USP17L7 indirectly through alterations in ubiquitin-mediated proteasomal degradation.

UCH-L1 Inhibitor Inhibitor

668467-91-2sc-356182
10 mg
$200.00
1
(1)

A USP14 inhibitor, which might impact USP17L7 activity by influencing ubiquitin-dependent proteolysis.